XYMOGEN Saloxicin Description
-
Saloxicin™
-
(Salix Alba/Boselia Serrata)
-
Affects the Production of Arachidonic Acid-Derived Eicosanoids
-
Supports Cytokine Balance
-
Supports Joint Comfort
-
Contains 40 mg Proprietary Bioflavonoid Berry Blend
-
Supports Antioxidant Mechanisms
-
Professional Formulas
Saloxicin™ is formulated to support eicosanoid and cytokine balance and provide support for joint comfort. 5-LOXIN®, a patented Boswellia extract yielding concentrated 3-O-acetyl-11-keto-B-boswellic acid (AKBA), is found to inhibit the 5-lipoxygenase enzyme. Salicin from white willow bark is a natural inhibitor of both the COX-2 and 5-lipoxygenase enzymes. Bioflavonoid-rich BerryVin™ provides additional support for eicosanoid balance and antioxidant activity.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
| Amount Per Serving | % Daily Value | |
| Salicin (from white willow extract (Salix alba) (bark)) | 120 mg | * |
| Boswellia Serrata extract (gum resin) (30% S-O-Acetyl-11-keto-B-Boswellic acid [AKBA]) | 50 mg | * |
| High ORAC Berry Blend (strawberries, escobillo, blueberries, cranberries, grape extract, pomegranate extract) (fruit) (ORAC >4,000 u/TE/g) | 40 mg | * |
Consult your healthcare professional prior to use. Individuals taking medication should discuss potential interactions with their healthcare professional.
